Find information on Urinary Tract Infection with Hematuria, including clinical documentation, medical coding, ICD-10 codes N30.0 and N39.0, and SNOMED CT concepts. Learn about diagnosis, treatment, and healthcare best practices for UTI with Hematuria. This resource provides guidance for physicians, nurses, and other healthcare professionals on accurate documentation and coding for this condition. Explore resources related to hematuria diagnosis, UTI symptoms, and urinary tract infection treatment.
Infection of the urinary tract, often causing painful urination.
Burning with urination, frequent urination, blood in urine, back/pelvic pain.
Community-acquired, hospital-acquired, catheter-associated.
Complete code families applicable to N30.01
| Description | When to use |
|---|---|
| UTI with Hematuria | Symptomatic UTI (dysuria, frequency) AND visible or microscopic blood in urine. |
| Cystitis | Lower UTI symptoms (dysuria, frequency, urgency) WITHOUT systemic infection signs. |
| Kidney stones | Severe flank pain radiating to groin, possible hematuria, nausea, vomiting. |
Using a generic UTI code (N39.0) without specifying hematuria (N02.x) leads to undercoding and lost revenue.
Incorrectly coding hematuria as the primary diagnosis instead of the UTI can impact DRG assignment and reimbursement.
Insufficient documentation of UTI and hematuria symptoms and diagnostic results can trigger audit denials and compliance issues.
Confirm hematuria: Verify presence of red blood cells in urine.
Symptoms check: Dysuria, frequency, urgency, suprapubic pain?
Urinalysis ordered: Evaluate for bacteria, leukocytes, nitrites.
Culture if indicated: Consider for recurrent UTIs, risk factors.
Consider alternate diagnoses: Stones, malignancy, trauma, medications.
Patient presents with symptoms consistent with urinary tract infection (UTI) with hematuria. The patient reports dysuria, urinary frequency, urgency, and notably, visible blood in the urine (gross hematuria). Onset of symptoms began approximately [Number] days ago and has progressively worsened. Patient denies fever, chills, flank pain, nausea, or vomiting. Medical history includes [List medical history relevant to UTI or hematuria e.g., hypertension, diabetes, previous UTIs, kidney stones, etc.]. Physical examination reveals [Document relevant physical exam findings e.g., suprapubic tenderness, costovertebral angle tenderness or lack thereof]. Urinalysis reveals positive leukocyte esterase, nitrites, and red blood cells confirming the diagnosis of UTI with hematuria. Differential diagnosis includes cystitis, pyelonephritis, urolithiasis, and bladder cancer. Given the absence of systemic symptoms and flank pain, pyelonephritis is less likely. Urolithiasis and bladder cancer are considered lower on the differential but warrant further investigation if hematuria persists after UTI treatment. A urine culture and sensitivity has been ordered to guide antibiotic therapy. The patient is prescribed [Antibiotic name and dosage] for [Number] days. Patient education provided on increasing fluid intake, proper hygiene practices, and the importance of completing the full course of antibiotics. Follow-up appointment scheduled in [Number] weeks to reassess symptoms and review urine culture results. Patient advised to return sooner if symptoms worsen or new symptoms develop such as fever, chills, or flank pain. ICD-10 code N30.0, Urinary tract infection, site not specified, with hematuria, is documented for billing and coding purposes.
In a patient presenting with UTI and gross hematuria without other concerning symptoms (e.g., flank pain, history of urolithiasis), initial evaluation should include urinalysis with microscopy, urine culture, and basic metabolic panel. If the urinalysis confirms infection and hematuria, and cultures are positive, treatment for the UTI should be initiated. Resolution of hematuria should be confirmed with a repeat urinalysis after the completion of antibiotic therapy. Explore how persistent hematuria after successful UTI treatment warrants further investigation, including imaging studies like CT urography or cystoscopy to rule out underlying urologic pathology. Consider implementing this stepped approach to avoid unnecessary imaging in uncomplicated cases.
Microscopic hematuria associated with a UTI is identified by the presence of red blood cells on urine microscopy, often without visible discoloration of the urine. Gross hematuria, however, presents as visibly bloody or discolored urine. In female patients, distinguishing between UTI-related hematuria and other causes requires careful assessment. A thorough history, including menstrual history, sexual activity, and use of medications (like anticoagulants), is crucial. Urinalysis with microscopy and urine culture are essential for confirming infection. While microscopic hematuria can be a common finding in UTI, gross hematuria warrants a more comprehensive evaluation, especially if it persists after UTI treatment. Learn more about the potential gynecological causes of hematuria that can mimic UTI symptoms.
For male patients with UTI and microscopic hematuria, the decision to pursue imaging studies should be guided by clinical context. Factors such as age, history of urological issues (e.g., kidney stones, BPH), and persistent hematuria following appropriate antibiotic treatment for the UTI should be considered. While uncomplicated UTI with microscopic hematuria may not require immediate imaging, the American Urological Association (AUA) guidelines recommend evaluating persistent microscopic hematuria, even in the absence of other symptoms. Consider implementing a risk-stratified approach, reserving imaging for patients with risk factors or those with unresolved hematuria after UTI treatment. Explore how cystoscopy may be indicated in certain cases to directly visualize the bladder and urethra.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.